
Sign up to save your podcasts
Or


In this episode, I delve into Nvidia's strategic move, investing $50 million in Recursion, and examine how this collaboration is revolutionizing drug discovery through AI technologies.
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
By Jaeden Schafer3.6
77 ratings
In this episode, I delve into Nvidia's strategic move, investing $50 million in Recursion, and examine how this collaboration is revolutionizing drug discovery through AI technologies.
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

229,674 Listeners

44,999 Listeners

16,313 Listeners

2,672 Listeners

1,105 Listeners

113,121 Listeners

9,556 Listeners

10,254 Listeners

551 Listeners